| CAR | Chimeric antigen receptor |
| ITIM | immune tyrosine-based inhibitory motif |
| MAC | membrane attacking complex |
| FcγR | Fc-gamma receptor |
| ITAM | immune tyrosine-based activation motif |
| mAbs | monoclonal antibodies |
| NHL | non-Hodgkin lymphoma |
| CLL | chronic lymphocytic leukemia |
| CTCL | cutaneous T cell lymphoma |
| PTCL | peripheral T cell lymphoma |
| NK | natural killer |
| DCs | dendritic cells |
| TM4SF | transmembrane-four superfamily proteins |
| TEM | tetraspanin-enriched membrane microdomain |
| CXCL | chemokine (C-X-C motif) ligand |
| APC | antigen-presenting cell |
| MHC | major histocompatibility complex |
| TCR | T cell receptor |
| BCR | B cell receptor |
| VCAM-1 | vascular cell adhesion molecule-1 |
| EV | extracellular vesicles |
| SOCS3 | suppressor of cytokine signaling 3 |
| Bcl-2 | B cell lymphoma 2 |
| R-CHOP | rituximab+chemotherapy |
| DLBCL | diffuse large B cell lymphoma |
| IPI | International Prognostic Index |
| PKC | protein kinase C |
| Jak | Janus Kinase |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| PI3K | phosphatidylinositol 3-kinase |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| FoxO3a | Forkhead box O3 |
| GSK3 | glycogen synthase kinase 3 |
| AML | acute myeloid leukemia |
| NSCLC | non-small cell lung cancer |
| IL | interleukin |
| IgG | Immunoglobulin G |
| SHP-1 | Src homology region 2 domain-containing phosphatase-1 |
| IL-7R | interleukin-7 receptor |
| CDC | complement-dependent cytotoxicity |
| ADCC | antibody-dependent cellular cytotoxicity |
| ADCP | antibody-dependent cellular phagocytosis |
| PDX | patient derived xenografts |
| scFv | single-chain variable fragment |
| MCL | mantle cell lymphoma |